These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 32602883)

  • 41. SARS-CoV-2: An immunogenetics call to arms.
    Clark B; Poulton K
    Int J Immunogenet; 2020 Aug; 47(4):319-323. PubMed ID: 32654378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytokine release syndrome in severe COVID-19.
    Moore JB; June CH
    Science; 2020 May; 368(6490):473-474. PubMed ID: 32303591
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunological environment shifts during pregnancy may affect the risk of developing severe complications in COVID-19 patients.
    Sarapultsev A; Sarapultsev P
    Am J Reprod Immunol; 2020 Sep; 84(3):e13285. PubMed ID: 32516444
    [No Abstract]   [Full Text] [Related]  

  • 44. Investigating Low-Dose Thoracic Radiation as a Treatment for COVID-19 Patients to Prevent Respiratory Failure.
    Wilson GD; Mehta MP; Welsh JS; Chakravarti A; Rogers CL; Fontanesi J
    Radiat Res; 2020 Jul; 194(1):1-8. PubMed ID: 32845978
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of Neutrophil Extracellular Traps in Covid-19: Only an hypothesis or a potential new field of research?
    Mozzini C; Girelli D
    Thromb Res; 2020 Jul; 191():26-27. PubMed ID: 32360977
    [No Abstract]   [Full Text] [Related]  

  • 46. Cytokine Storms: Understanding COVID-19.
    Mangalmurti N; Hunter CA
    Immunity; 2020 Jul; 53(1):19-25. PubMed ID: 32610079
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brief annotations on cytokine release syndrome and interleukin-6 therapeutic blockage in SARS-CoV-2/COVID-19.
    Amezcua-Guerra LM
    Arch Cardiol Mex; 2020; 90(Supl):84-87. PubMed ID: 32523147
    [No Abstract]   [Full Text] [Related]  

  • 48. How does COVID-19 kill? Uncertainty is hampering doctors' ability to choose treatments.
    Ledford H
    Nature; 2020 Apr; 580(7803):311-312. PubMed ID: 32273618
    [No Abstract]   [Full Text] [Related]  

  • 49. Infection risk of dermatologic therapeutics during the COVID-19 pandemic: an evidence-based recalibration.
    Ghazawi FM; Lim M; Dutz JP; Kirchhof MG
    Int J Dermatol; 2020 Sep; 59(9):1043-1056. PubMed ID: 32621284
    [TBL] [Abstract][Full Text] [Related]  

  • 50. After 62 years of regulating immunity, dexamethasone meets COVID-19.
    Cain DW; Cidlowski JA
    Nat Rev Immunol; 2020 Oct; 20(10):587-588. PubMed ID: 32778829
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Low dose lung radiotherapy for COVID-19-related cytokine storm syndrome: Why not?].
    Cosset JM; Deutsch É; Bazire L; Mazeron JJ; Chargari C
    Cancer Radiother; 2020 Jun; 24(3):179-181. PubMed ID: 32389579
    [No Abstract]   [Full Text] [Related]  

  • 52. Will helminth co-infection modulate COVID-19 severity in endemic regions?
    Bradbury RS; Piedrafita D; Greenhill A; Mahanty S
    Nat Rev Immunol; 2020 Jun; 20(6):342. PubMed ID: 32358579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
    Wang Q; Hu Z
    Int J Infect Dis; 2020 Jul; 96():618-620. PubMed ID: 32470601
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Signals of T
    Roncati L; Nasillo V; Lusenti B; Riva G
    Ann Hematol; 2020 Jun; 99(6):1419-1420. PubMed ID: 32382776
    [No Abstract]   [Full Text] [Related]  

  • 55. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.
    Han H; Ma Q; Li C; Liu R; Zhao L; Wang W; Zhang P; Liu X; Gao G; Liu F; Jiang Y; Cheng X; Zhu C; Xia Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1123-1130. PubMed ID: 32475230
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The Management of Cytokine Storm in COVID-19.
    Rumende CM; Susanto EC; Sitorus TP
    Acta Med Indones; 2020 Jul; 52(3):306-313. PubMed ID: 33020343
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytokine Storm: Is it the only major death factor in COVID-19 patients? Coagulation role.
    Magro G
    Med Hypotheses; 2020 Sep; 142():109829. PubMed ID: 32428809
    [No Abstract]   [Full Text] [Related]  

  • 58. Possible mechanisms responsible for acute coronary events in COVID-19.
    Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
    Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19.
    Luo W; Li YX; Jiang LJ; Chen Q; Wang T; Ye DW
    Trends Pharmacol Sci; 2020 Aug; 41(8):531-543. PubMed ID: 32580895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A combinatorial approach of a polypharmacological adjuvant 2-deoxy-D-glucose with low dose radiation therapy to quell the cytokine storm in COVID-19 management.
    Verma A; Adhikary A; Woloschak G; Dwarakanath BS; Papineni RVL
    Int J Radiat Biol; 2020 Nov; 96(11):1323-1328. PubMed ID: 32910699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.